【Goldman Sachs (China) Securities Company Limited&Goldman Sachs (Asia) L.L.C.】【202610】Gan & Lee Pharmaceuticals Co. (603087.SS) GZR4's Phase III success highlights its competitive potential; TP up to Rmb78; Buy-9页
证券期货研究报告
Goldman Sachs (China) Securities Company Limited&Goldman Sachs (Asia) L.L.C.
卫生和社会工作
2026年
PDF
9.51 MB